← Mereo BioPharma Group plc
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $36.5m |
$0
-100.00%
|
$10.0m |
$0
-100.00%
|
$500k |
$500k
0.00%
|
|
| Cost of Goods and Services Sold | — | — | — | — | $17.9m |
($936k)
-105.23%
|
$4.9m
+624.70%
|
$0
-100.00%
|
$246k |
$133k
-45.84%
|
|
| Cost of revenue | — | — | — | — | ($17.9m) |
$936k
+105.23%
|
$2.6m
+175.00%
|
$0
-100.00%
|
$133k |
$133k
0.00%
|
|
| Net Interest Income | — | — | — | — | — | — | ($750k) |
$1.7m
+322.80%
|
$1.9m
+14.78%
|
$1.7m
-8.97%
|
|
| Gross Profit | — | — | — | — | $18.6m |
$35.5m
+91.46%
|
$7.4m
-79.10%
|
$0
-100.00%
|
$367k |
$367k
0.00%
|
|
| Research And Development | $34.6m | $22.7m | $23.6m | $16.3m | $23.6m | $25.0m | $17.4m | $20.9m | $17.8m | $18.6m | |
| Research and development expenses | ($34.6m) | ($22.7m) | ($23.6m) | ($16.3m) | ($23.6m) | ($25.0m) | — | — | — | $18.6m | |
| General and Administrative Expense | — | — | — | — | — | — | $18.4m | $26.4m | $23.0m | $19.8m | |
| Amortization of Intangible Assets | — | — | — | — | — | — | $395k | $438k | $465k | — | |
| Operating expenses: | |||||||||||
| Operating Costs and Expenses | — | — | — | — | — | — | $700k | $700k | $700k | — | |
| Other Operating Expenses | — | — | — | — | — | — | ($1.3m) | ($1.6m) | ($2.1m) | — | |
| Other Operating Income Expense | ($45.3m) | ($34.5m) | ($39.5m) | ($37.6m) | ($20.9m) | $811k | ($27.1m) | ($41.9m) | ($41.6m) | — | |
| Operating Income (Loss) | ($45.3m) |
($34.5m)
+23.90%
|
($39.5m)
-14.62%
|
($37.6m)
+4.93%
|
($20.9m)
+44.27%
|
($43.6m)
-108.11%
|
($28.4m)
+34.78%
|
($47.4m)
-66.68%
|
($40.1m)
+15.32%
|
($35.9m)
+10.46%
|
|
| Interest Expense | — | — | — | — | — | — | $2.9m | $1.4m | $255k | $95k | |
| Interest Expense On Lease Liabilities | — | — | $1.3m | $1.1m | $227k | $209k | — | — | — | $95k | |
| Interest Income, Operating | — | — | — | — | — | — | — | — | $104k | $1.8m | |
| Interest Income | — | — | — | — | — | — | $2.1m | $3.0m | $2.2m | $1.8m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | — | ($750k) | $1.7m | $1.9m | $1.7m | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | — | ($2.3m) | $1.2m | ($6.3m) | — | |
| Gain On Sale Of PPE | — | — | — | — | $153k | $0 | — | — | — | $0 | |
| Gain On Sale Of Security | — | — | — | — | — | — | ($2.1m) | $791k | ($5.5m) | ($1.5m) | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | — | — | — | — | $245k | ($419k) | $805k | — | |
| Other Income | — | — | — | — | — | — | — | — | $300k | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | — | — | $1.0m | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | ($10k) | $0 | $300k | — | |
| Other Income Expense | — | — | — | — | — | — | ($2.1m) | $791k | ($5.5m) | ($1.5m) | |
| Pre-Tax Income | — | — | — | — | — | — | ($30.0m) | ($43.3m) | ($41.9m) | ($35.7m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | — | ($30.0m) | ($43.3m) | ($41.9m) | ($35.7m) | |
| Current Tax Expense (Income) | — | — | — | — | $1.5m | ($601k) | — | — | — | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | — | $3k | — | — | — | — | — | — | — | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | $532k | $0 | $0 | $0 | |
| Income Tax Expense Continuing Operations | ($8.2m) | ($5.3m) | ($6.3m) | ($2.8m) | $1.5m | ($1.9m) | — | — | — | $0 | |
| Net Income From Continuing And Discontinued Operation | — | — | — | — | — | — | ($29.5m) | ($43.3m) | ($41.9m) | ($35.7m) | |
| Earnings Per Share, Basic | — | — | ($0.39) | ($0.48) | $0.02 | ($0.06) | ($0.04) | ($0.06) | ($0.05) | ($0.20) | |
| Earnings Per Share, Diluted | ($0.56) | ($0.45) | ($0.39) | ($0.48) | ($0.05) | ($0.06) | ($0.04) | ($0.06) | ($0.05) | ($0.20) | |
| Basic Earnings (Loss) Per Share | — | — | ($0.39) | ($0.48) | $0.02 | ($0.06) | ($0.20) | ($0.30) | ($0.25) | ($0.20) | |
| Diluted Earnings (Loss) Per Share | ($0.56) | ($0.45) | ($0.39) | ($0.48) | ($0.05) | ($0.06) | ($0.04) | ($0.06) | ($0.05) | ($0.20) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | — | 659.5m | 739.6m | 797.1m | 160.3m | |
| Basic Average Shares | — | — | — | — | — | — | $131.9m | $147.9m | $159.4m | $160.3m | |
| Diluted Average Shares | — | — | — | — | — | — | $131.9m | $147.9m | $159.4m | $160.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | — | 659.5m | 739.6m | 797.1m | 160.3m | |
| Additional Financial Items | |||||||||||
| Applicable Tax Rate | $0 | $0 | — | — | — | — | — | — | — | — | |
| Depreciation Right of Use Assets | — | — | $1.5m | $1.5m | $570k | $583k | — | — | — | — | |
| Finance Income | $827k | $307k | $377k | $44k | $1k | $696k | — | — | — | — | |
| Income (Loss) Attributable to Parent, before Tax | — | — | — | — | — | — | $30.0m | $43.3m | ($41.9m) | — | |
| Profit Loss Attributable To Owners Of Parent | ($38.8m) | ($32.0m) | ($34.8m) | ($163.6m) | $12.7m | ($34.2m) | — | — | — | — | |
| Profit Loss Before Tax | ($47.0m) | ($37.3m) | ($41.1m) | ($166.4m) | $14.2m | ($36.1m) | — | — | — | — | |
| Profit Loss From Operating Activities | ($45.3m) | ($35.2m) | ($39.5m) | ($37.6m) | ($20.9m) | ($43.6m) | — | — | — | — | |
| Changes in the fair value of financial instruments | — | $716k | $875k | ($109.8m) | $40.0m | $7.8m | — | — | — | — | |
| Gain/(loss) on disposal of intangible assets | — | — | — | ($10.9m) | $113k | — | — | — | — | — | |
| Net foreign exchange gain/(loss) | ($1.4m) | ($44k) | $483k | ($1.8m) | ($954k) | $1.5m | — | — | — | — | |
| (Loss)/profit before tax | ($47.0m) | ($37.3m) | ($41.1m) | ($166.4m) | $14.2m | ($36.1m) | — | — | — | — | |
| Taxation | $8.2m | $5.3m | $6.3m | $2.8m | ($1.5m) | $1.9m | — | — | — | — | |
| (Loss)/profit for the year, attributable to equity holders of the parent | ($38.8m) | ($32.0m) | ($34.8m) | ($163.6m) | $12.7m | ($34.2m) | — | — | — | — | |
| Currency translation of foreign operations | — | — | ($499k) | $349k | ($191k) | ($1.8m) | — | — | — | — | |
| Average Dilution Earnings | — | — | — | — | ($52.0m) | $0 | — | — | — | $0 | |
| Diluted EPS | — | — | — | — | — | — | ($0.20) | ($0.30) | ($0.25) | ($0.20) | |
| Diluted NI Availto Com Stockholders | — | — | — | — | — | — | ($29.5m) | ($43.3m) | ($41.9m) | ($35.7m) | |
| Normalized EBITDA | — | — | — | — | — | — | ($24.0m) | ($41.6m) | ($34.9m) | ($34.4m) | |
| Normalized Income | — | — | — | — | — | — | ($27.4m) | ($44.0m) | ($36.3m) | ($34.2m) | |
| Other Gand A | — | — | — | — | — | — | $18.4m | $26.4m | $23.0m | — | |
| Reconciled Depreciation | — | — | — | — | — | — | $1.1m | $1.1m | $1.1m | $1.2m | |
| Selling General And Administration | — | — | — | — | — | — | $18.4m | $26.4m | $23.0m | — | |
| Special Income Charges | — | — | — | — | $153k | $0 | — | — | — | $82k | |
| Tax Effect Of Unusual Items | — | — | — | — | — | — | ($38k) | $0 | $0 | $0 | |
| Tax Provision | — | — | — | — | — | — | ($532k) | $0 | $0 | $0 | |
| Tax Rate For Calcs | — | — | — | — | — | — | $0 | $0 | $0 | $0 | |
| Administrative Expense | $10.7m | $12.5m | $15.9m | $21.2m | $15.9m | $19.5m | — | — | — | — | |
| Employee Benefits Expense | $9.3m | $6.2m | $8.0m | $10.7m | $12.2m | $14.2m | — | — | — | — | |
| Expense From Share-Based Payment Transactions With Employees | $3.7m | $2.2m | $1.6m | $1.6m | $3.3m | $3.9m | — | — | — | — | |
| Finance Costs | $1.1m | $2.4m | $3.5m | $6.4m | $4.0m | $3.4m | — | — | — | — | |
| Administrative expenses | ($10.7m) | ($11.8m) | ($15.9m) | ($21.2m) | ($15.9m) | ($19.5m) | — | — | — | — | |
| Operating Expense | — | — | — | — | — | — | $34.6m | $45.7m | $38.6m | $36.4m | |
| Total comprehensive (loss)/income for the year, attributable to equity holders of the parent | ($38.8m) | ($32.0m) | ($35.3m) | ($163.3m) | $12.5m | ($36.0m) | — | — | — | — | |
| Total Unusual Items | — | — | — | — | — | — | ($2.1m) | $791k | ($5.5m) | ($1.5m) | |
| Total Expenses | — | — | — | — | — | — | $37.1m | $45.7m | $38.8m | $36.4m | |
| Total Other Finance Cost | — | — | — | — | $28k | $50k | — | — | — | $45k |